These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2903342)

  • 1. Thalidomide for graft-versus-host disease.
    McCarthy DM; Kanfer E; Taylor J; Barrett AJ
    Lancet; 1988 Nov; 2(8620):1135. PubMed ID: 2903342
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide for graft-versus-host disease after bone marrow transplantation.
    Saurat JH; Camenzind M; Helg C; Chapuis B
    Lancet; 1988 Feb; 1(8581):359. PubMed ID: 2893167
    [No Abstract]   [Full Text] [Related]  

  • 3. Thalidomide for the therapy of graft-versus-host disease following allogeneic bone marrow transplantation.
    McCarthy DM; Kanfer EJ; Barrett AJ
    Biomed Pharmacother; 1989; 43(9):693-7. PubMed ID: 2696566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thalidomide for severe acute graft-versus-host disease.
    Ringdén O; Aschan J; Westerberg L
    Lancet; 1988 Sep; 2(8610):568. PubMed ID: 2900947
    [No Abstract]   [Full Text] [Related]  

  • 5. Thalidomide back in good graces--seems to help GVHD patients.
    Oncology (Williston Park); 1988 Sep; 2(9):29. PubMed ID: 3275064
    [No Abstract]   [Full Text] [Related]  

  • 6. Thalidomide in the management of chronic graft-versus-host disease in children following bone marrow transplantation.
    Cole CH; Rogers PC; Pritchard S; Phillips G; Chan KW
    Bone Marrow Transplant; 1994 Dec; 14(6):937-42. PubMed ID: 7711671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment with thalidomide of acute graft-versus-host disease after bone-marrow transplantation.
    Lim SH; McWhannell A; Vora AJ; Boughton BJ
    Lancet; 1988 Jan; 1(8577):117. PubMed ID: 2891954
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of thalidomide in the treatment of refractory chronic graft-versus-host disease following bone marrow transplantation in children.
    Rovelli A; Arrigo C; Nesi F; Balduzzi A; Nicolini B; Locasciulli A; Vassallo E; Miniero R; Uderzo C
    Bone Marrow Transplant; 1998 Mar; 21(6):577-81. PubMed ID: 9543061
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thalidomide for the treatment of chronic graft-versus-host disease.
    Vogelsang GB; Farmer ER; Hess AD; Altamonte V; Beschorner WE; Jabs DA; Corio RL; Levin LS; Colvin OM; Wingard JR
    N Engl J Med; 1992 Apr; 326(16):1055-8. PubMed ID: 1549151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thalidomide in children undergoing bone marrow transplantation: series at a single institution and review of the literature.
    Mehta P; Kedar A; Graham-Pole J; Skoda-Smith S; Wingard JR
    Pediatrics; 1999 Apr; 103(4):e44. PubMed ID: 10103336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thalidomide in the treatment of graft-versus-host disease.
    Heney D; Bailey CC; Lewis IJ
    Biomed Pharmacother; 1990; 44(4):199-204. PubMed ID: 2204450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide].
    Pédailles S; Troussard X; Launay V; Bazin A; Sentias C; Surbled M
    Presse Med; 1993 Jan 2-16; 22(1):37. PubMed ID: 8469665
    [No Abstract]   [Full Text] [Related]  

  • 13. Chronic graft-versus-host disease revealed by lichenoid vulvar lesions successfully treated with thalidomide.
    Staumont-Sallé D; Magro L; Piette F; Thomas P; Jouet JP; Catteau B
    Acta Derm Venereol; 2003; 83(4):302-3. PubMed ID: 12926809
    [No Abstract]   [Full Text] [Related]  

  • 14. The use of thalidomide in chronic refractory graft versus host disease.
    van de Poel MH; Pasman PC; Schouten HC
    Neth J Med; 2001 Aug; 59(2):45-9. PubMed ID: 11476911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Thalidomide 1989].
    Codina C
    Med Clin (Barc); 1989 Apr; 92(15):571-2. PubMed ID: 2666770
    [No Abstract]   [Full Text] [Related]  

  • 16. Thalidomide for chronic graft-versus-host disease in children.
    Heney D; Lewis IJ; Bailey CC
    Lancet; 1988 Dec; 2(8623):1317. PubMed ID: 2904042
    [No Abstract]   [Full Text] [Related]  

  • 17. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
    Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
    Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thalidomide as therapy for intestinal chronic GVHD.
    Lopez J; Ulibarrena C; Garcia-Laraña J; Odriozola J; Pérez de Oteyza J; Sastre JL; Navarro JL
    Bone Marrow Transplant; 1993 Mar; 11(3):251-2. PubMed ID: 8467293
    [No Abstract]   [Full Text] [Related]  

  • 19. Thalidomide treatment for chronic graft-versus-host disease.
    Heney D; Norfolk DR; Wheeldon J; Bailey CC; Lewis IJ; Barnard DL
    Br J Haematol; 1991 May; 78(1):23-7. PubMed ID: 2043478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of thalidomide for CGVHD defended.
    Altomonte V
    Oncol Nurs Forum; 1993 Apr; 20(3):428. PubMed ID: 8497414
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.